XML 32 R25.htm IDEA: XBRL DOCUMENT v3.21.4

RESEARCH AND DEVELOPMENT (Tables)

12 Months Ended

Sep. 30, 2021

Research And Development [Abstract]

Disclosure of research and development expenses [Table Text Block]

	Year ended	Year ended	Period ended
	September 30, 2021	September 30, 2020	September 30, 2019
	$	$	$
Laboratory costs (see Note 11)	82,871	25,874	27,164
Novel drug development	3,638,910	110,029	-
Patents and related payments	513,302	13,895	-
Salary and subcontractors	1,369,769	43,754	14,845
Share-based compensation (see Note 6)	709,136	161,300	-
	6,313,988	354,852	42,009

X

- Definition

Disclosure of detailed information about research and development.

+ References

No definition available.

+ Details

Name:	drug_DisclosureOfDetailedInformationAboutResearchAndDevelopmentExplanatory
Namespace Prefix:	drug_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	drug_ResearchAndDevelopmentAbstract
Namespace Prefix:	drug_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration